NPS PHARMACEUTICALS INC 4
4 · NPS PHARMACEUTICALS INC · Filed Feb 24, 2015
Insider Transaction Report
Form 4
Selisker Rachel R
Director
Transactions
- Disposition to Issuer
Restricted Stock Units
2015-02-21−3,816→ 0 total→ Common Stock (3,816 underlying) - Disposition to Issuer
Deferred Stock Units
2015-02-21−144,074→ 0 total→ Common Stock (144,074 underlying) - Disposition from Tender
Common Stock
2015-02-21$46.00/sh−7,400$340,400→ 0 total
Footnotes (6)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of NPS Pharmaceuticals, Inc.'s (the "Issuer") common stock.
- [F2]On February 12, 2015, the Restricted Stock Units were granted with one hundred percent vesting on the first anniversary of date of grant.
- [F3]In connection with the merger of Knight Newco 2, Inc. with and into the Issuer on February 21, 2015, each outstanding Restricted Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Restricted Stock Unit.
- [F4]Each Deferred Stock Unit represents a right to receive one share of the Issuer's common stock.
- [F5]Deferred Stock Units are vested in full on the date of grant and will be settled in the Issuer's common stock upon (1) separation from service on the Board, (2) death, (3) disability or (4) a sale of substantially all the assets of the Issuer.
- [F6]In connection with the merger of Knight Newco 2, Inc. with and into the Issuer on February 21, 2015, each outstanding Deferred Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Deferred Stock Unit.